7-Nitroindazole
2942-42-9
97%
2026-06-30
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Product Description
-
Seller Information
-
Description
ProductName 7-Nitroindazole Cat No CEI-0643 Description A non-selective, reversible and competitive inhibitor of NOS isoforms in vitro. The IC50 values for inhibition of rat nNOS, bovine eNOS, and rat iNOS are 0.71, 0.78, and 5.8 µM, respectively. However, it shows good anti-nociceptive effects in vivo without affecting blood pressure via inhibition of eNOS. Alias 7-NI Appearance White solid Product Overview A non-selective, reversible and competitive inhibitor of NOS isoforms in vitro. CAS No 2942-42-9 Molecular Weight 241.72 Purity >97% by TLC Storage -20 centigrade Synonyms 7-NI Targets Nos1, NOS3, Nos2 Molecular Formula C7H5N3O2 Chemical Name 7-nitro-1H-indazole Solubility H₂O (~ 50 mg/ml) Shipping Conditions Gel pack category Specialty Chemicals(c26) cas_num 2942-42-9 Basic Info-
Product Name:
7-Nitroindazole
Other Name:1H-Indazole,7-nitro-;7-Nitro-1H-indazole;7-Nitroindazole;NSC 72843
CAS No.:2942-42-9
Molecular Formula:C7H5N3O2
InChIKeys:InChIKey=PQCAUHUKTBHUSA-UHFFFAOYSA-N
Molecular Weight:163.136
Exact Mass:163.13
EC Number:220-934-4
UNII:UX0N37CMVH
NSC Number:72843
DSSTox ID:DTXSID30183638
HScode:2933990090
Categories:
Characteristics-
PSA:
74.5
XLogP3:1.8
Appearance:Orange-Yellow Solid
Density:1.5±0.1 g/cm3
Melting Point:186.5-187.5 °C
Boiling Point:383.3°C at 760 mmHg
Flash Point:81.5±22.6 °C
Refractive Index:1.741
Water Solubility:H2O: slightly soluble
Storage Conditions:-20ºC
Vapor Pressure:9.79E-06mmHg at 25°C
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 3, Oral
Eye irritation, Category 2
Carcinogenicity, Category 2
Reproductive toxicity, Category 1B
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H301 Toxic if swallowed
H319 Causes serious eye irritation
H351 Suspected of causing cancer
H360 May damage fertility or the unborn child
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P203 Obtain, read and follow all safety instructions before use.
Response P301+P316 IF SWALLOWED: Get emergency medical help immediately.
P321 Specific treatment (see ... on this label).
P330 Rinse mouth.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P318 IF exposed or concerned, get medical advice.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Location:
Shirley, New York 11967, USA
-
Payment Terms:
TT against copy of documents,D/P
-
Average lead Time:
15
-
Total Annual Revenue:
$1 million-$2.5 million
-
Year of Establishment:
2004
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product